1992The Tohoku Journal of Experimental MedicineOpen access

Augmented Accumulation of Transferred Lymphokine-Activated Killer(LAK) Cells at Murine Tumor Sites through Production of LAK-Attractant Facilitated by Chemotherapy.

Masuo Hosokawa, Yoshitaka Wakizaka, Yasuhiro Kuramitsu, Mark Micallef, YUHJI TOGASHI, Hiroshi Kobayashi

Open full text 3 citations

Abstract

HOSOKAWA, M., WAKIZAKA, Y., KURAMITSU, Y., MICALLEF, M., TOGASHI, Y. and KOBAYASHI, H. Augmented Accumulation of Transferred Lymphokine- Activated Killer (LAK) Cells at Murine Tumor Sites through Production of LAK-Attractant Facilitated by Chemotherapy. Tohoku J. Exp. Med., 1992, 168 (2), 413-416- We observed that effects of adoptive immunotherapy with lymphokine-activated killer (LAK) cells on BMT-11, a fibrosarcoma in C57BL/6 mice were improved by combination with cyclophosphamide (CY)-chemotherapy corresponding to enhanced accumulation at tumor sites of LAK cells. On the other hand, cytotoxic T lymphocytes (CTLs) which were able to accumulate at tumor sites more densely than LAK cells produced significant therapeutic effects by themselves. We have also found observed that LAK-attractant activity was detected in conditioned medium (CM) of CY-treated tumor tissue but not in the CM of untreated tumor tissue. These findings reveal that CY-chemotherapy facilitates LAK-attractant-production and enhances the accumulation in tumor tissue of LAK cells and that therapeutic effects of adoptive transfer of LAK cells are augmented by cancer chemotherapy through the enhanced accumulation of LAK cells.- lymphokine-activated killer; fibrosarcoma; cytotoxic T lymphocyte; adoptive transfer; cyclophosphamide

Open-access reader

About this research paper

What this paper is about

HOSOKAWA, M., WAKIZAKA, Y., KURAMITSU, Y., MICALLEF, M., TOGASHI, Y. and KOBAYASHI, H. Augmented Accumulation of Transferred Lymphokine- Activated Killer (LAK) Cells at Murine Tumor Sites through Production of LAK-Attractant Facilitated by Chemotherapy. Tohoku J. Exp. Med., 1992, 168 (2), 413-416- We observed that effects of adoptive immunotherapy with lymphokine-activated killer (LAK) cells on BMT-11, a fibrosarcoma in C57BL/6 mice were improved by combination with cyclophosphamide (CY)-chemotherapy corresponding to enhanced accumulation at tumor sites of LAK cells. On the other hand, cytotoxic T lymphocytes (CTLs) which were able to accumulate at tumor sites more densely than LAK cells produced significant therapeutic effects by themselves. We have also found observed that LAK-attractant activity was detected in conditioned medium (CM) of CY-treated tumor tissue but not in the CM of untreated tumor tissue. These findings reveal that CY-chemotherapy facilitates LAK-attractant-production and enhances the accumulation in tumor tissue of LAK cells and that therapeutic effects of adoptive transfer of LAK cells are augmented by cancer chemotherapy through the enhanced accumulation of LAK cells.- lymphokine-activated killer; fibrosarcoma; cytotoxic T lymphocyte; adoptive transfer; cyclophosphamide

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

HOSOKAWA, M., WAKIZAKA, Y., KURAMITSU, Y., MICALLEF, M., TOGASHI, Y. and KOBAYASHI, H. Augmented Accumulation of Transferred Lymphokine- Activated Killer (LAK) Cells at Murine Tumor Sites through Production of LAK-Attractant Facilitated by Chemotherapy. Tohoku J. Exp. Med., 1992, 168 (2), 413-416- We observed that effects of adoptive immunotherapy with lymphokine-activated killer (LAK) cells on BMT-11, a fibrosarcoma in C57BL/6 mice were improved by combination with cyclophosphamide (CY)-chemotherapy corresponding to enhanced accumulation at tumor sites of LAK cells. On the other hand, cytotoxic T lymphocytes (CTLs) which were able to accumulate at tumor sites more densely than LAK cells produced significant therapeutic effects by themselves. We have also found observed that LAK-attractant activity was detected in conditioned medium (CM) of CY-treated tumor tissue but not in the CM of untreated tumor tissue. These findings reveal that CY-chemotherapy facilitates LAK-attractant-production and enhances the accumulation in tumor tissue of LAK cells and that therapeutic effects of adoptive transfer of LAK cells are augmented by cancer chemotherapy through the enhanced accumulation of LAK cells.- lymphokine-activated killer; fibrosarcoma; cytotoxic T lymphocyte; adoptive transfer; cyclophosphamide

Key concepts: Lymphokine-activated killer cell, Adoptive cell transfer, Cytotoxic T cell, Lymphokine, Adoptive immunotherapy, Cancer research, Fibrosarcoma, Chemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Augmented Accumulation of Transferred Lymphokine-Activated Killer(LAK) Cells at Murine Tumor Sites through Production of LAK-Attractant Facilitated by Chemotherapy. — Research Paper | ScholarLens